Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001
Oncotarget · 2023
DOI: 10.18632/oncotarget.28341 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncotarget, 2023. Verfasst von Xiaofan Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Research Development, Sutro Biopharma, South San Francisco, CA 94080, USA. Hauptthemen laut MEDLINE: Immunoconjugates, Antineoplastic Agents, Multiple Myeloma, Lymphoma, Non-Hodgkin. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Development, Sutro Biopharma, South San Francisco, CA 94080, USA.
- Clinical Development, Sutro Biopharma, South San Francisco, CA 94080, USA.
Zitieren
APA
Li, X., Abrahams, C., Yu, A., Embry, M., Henningsen, R., DeAlmeida, V., Matheny, S., Kline, T., Yam, A., Stafford, R., Hallam, T., Lupher, M., & Molina, A. (2023). Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001. Oncotarget. https://doi.org/10.18632/oncotarget.28341
Vancouver
Li X, Abrahams C, Yu A, Embry M, Henningsen R, DeAlmeida V, et al. Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001. Oncotarget. 2023. doi:10.18632/oncotarget.28341
BibTeX
@article{Li2023,
author = {Li, Xiaofan and Abrahams, Cristina and Yu, Abigail and Embry, Millicent and Henningsen, Robert and DeAlmeida, Venita and Matheny, Shannon and Kline, Toni and Yam, Alice and Stafford, Ryan and Hallam, Trevor and Lupher, Mark and Molina, Arturo},
title = {Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001},
journal = {Oncotarget},
year = {2023},
doi = {10.18632/oncotarget.28341}
}
EUVIMED